GE HealthCare Technologies Inc. (NASDAQ:GEHC) Receives $92.17 Average Target Price from Brokerages

Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) have been assigned an average rating of “Hold” from the fourteen analysts that are presently covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and seven have assigned a buy rating to the company. The average twelve-month price objective among analysts that have covered the stock in the last year is $92.1667.

Several analysts have commented on GEHC shares. Jefferies Financial Group increased their target price on GE HealthCare Technologies from $95.00 to $105.00 and gave the company a “buy” rating in a research note on Thursday, December 11th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of GE HealthCare Technologies in a report on Monday, December 29th. Wall Street Zen cut GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, March 21st. Morgan Stanley lifted their price objective on GE HealthCare Technologies from $80.00 to $85.00 and gave the stock an “equal weight” rating in a report on Wednesday, February 4th. Finally, Citigroup decreased their target price on GE HealthCare Technologies from $88.00 to $84.00 and set a “neutral” rating for the company in a research report on Wednesday, March 11th.

GE HealthCare Technologies Stock Up 3.5%

Shares of GE HealthCare Technologies stock opened at $71.18 on Friday. The company has a 50-day simple moving average of $77.49 and a two-hundred day simple moving average of $78.18. The stock has a market capitalization of $32.48 billion, a PE ratio of 15.61, a price-to-earnings-growth ratio of 1.51 and a beta of 1.03. GE HealthCare Technologies has a 52-week low of $57.65 and a 52-week high of $89.77. The company has a debt-to-equity ratio of 0.91, a quick ratio of 1.13 and a current ratio of 1.37.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, February 4th. The company reported $1.44 EPS for the quarter, beating analysts’ consensus estimates of $1.40 by $0.04. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. The firm had revenue of $5.70 billion for the quarter, compared to analysts’ expectations of $5.60 billion. During the same quarter in the prior year, the company posted $1.45 earnings per share. The business’s revenue for the quarter was up 7.1% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. On average, analysts anticipate that GE HealthCare Technologies will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Friday, April 3rd will be paid a $0.035 dividend. The ex-dividend date is Thursday, April 2nd. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. GE HealthCare Technologies’s payout ratio is currently 3.07%.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in GEHC. E Fund Management Hong Kong Co. Ltd. raised its stake in GE HealthCare Technologies by 130.7% during the 3rd quarter. E Fund Management Hong Kong Co. Ltd. now owns 346 shares of the company’s stock valued at $26,000 after buying an additional 196 shares during the last quarter. Godsey & Gibb Inc. purchased a new position in shares of GE HealthCare Technologies in the 3rd quarter worth $26,000. Laurel Wealth Advisors LLC bought a new stake in shares of GE HealthCare Technologies in the fourth quarter worth $26,000. Optima Capital LLC purchased a new stake in GE HealthCare Technologies during the fourth quarter valued at $27,000. Finally, Godfrey Financial Associates Inc. purchased a new stake in GE HealthCare Technologies during the fourth quarter valued at $27,000. Institutional investors own 82.06% of the company’s stock.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.